Flecainide acetate and Exforge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flecainide acetate (flecainide acetate) and Exforge (amlodipine besylate; valsartan). Common drug interactions include arthralgia among females and blood creatine phosphokinase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Flecainide acetate and Exforge. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

On Jul, 08, 2026

18 people who take Flecainide acetate and Exforge together, and have interactions are studied.

Flecainide acetate and Exforge drug interactions.

What are the common drug interactions of Flecainide Acetate and Exforge, by gender? *:

female:

Arthralgia (joint pain)
Asthenia (weakness)
Back pain
Balance disorder
Blood calcium increased
Bone pain
Dizziness
Eye disorder
Fall
Fatigue (feeling of tiredness)

male:

Blood creatine phosphokinase increased
Atrioventricular block (heart block)
Cardiac failure congestive
Cardiac fibrillation (uncontrolled muscle contraction of heart)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)
Device related infection
Erysipelas (bacterial skin infection)
Face oedema (swelling of face)
Failure to thrive (inadequate weight gain and physical growth in children)

What are the common drug interactions of Flecainide Acetate and Exforge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Blood creatine phosphokinase increased
Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Head injury
Inner ear disorder
Limb asymmetry (consistent task discrepancy between the two lower limbs)
Motion sickness (travel sickness)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Muscle spasms (muscle contraction)
Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 22.22%
Osteoporosis (bones weak and more likely to break): 3 people, 16.67%
Enlarged Prostate: 2 people, 11.11%
Arrhythmias (irregular heartbeat): 2 people, 11.11%
Pain: 1 person, 5.56%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 5.56%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%
Gastroesophageal Cancer: 1 person, 5.56%
Diabetes: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Flecainide acetate and Exforge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously